|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K 14/535 | (2006.01) |
| (11) | Number of the document | 3381942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18157842.8 |
| Date of filing the European patent application | 2013-08-30 | |
| (97) | Date of publication of the European application | 2018-10-03 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261694963 P | 2012-08-30 | US | |
| 201361846147 P | 2013-07-15 | US |
| (72) |
VANDERWALDE, Ari, US
SHABOOTI, Mohamed, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
|
| (54) | A METHOD FOR TREATING MELANOMA USING A HERPES SIMPLEX VIRUS AND AN IMMUNE CHECKPOINT INHIBITOR |
| A METHOD FOR TREATING MELANOMA USING A HERPES SIMPLEX VIRUS AND AN IMMUNE CHECKPOINT INHIBITOR |